ArticleCancer immunology research2025

TLR5 Signaling Causes Dendritic Cell Dysfunction and Orchestrates Failure of Immune Checkpoint Therapy against Ovarian Cancer.

Mitchell T McGinty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.